Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility
Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally
Illumina secures CMS reimbursement for TruSight Oncology Comprehensive, expanding access to precision oncology
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
Red Metals Corp Invites Shareholders and Investment Community to Visit Them at Booth 2538 at PDAC 2026 in Toronto, March 1-4
Silver Hammer Closes CDN$3,913,617 Non-Brokered Private Placement Pursuant to Listed Issuer Exemption
